NCT05610059Completed
Improving Hypertension Medication Adherence for Older Adults
Source: ClinicalTrials.gov · Last updated 31 Jul 2026
Brief summary (registry, in English)
This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 25 Oct 2022
- Start date
- 2 Nov 2022
- Primary completion date
- 14 Mar 2025
- Lead sponsor
- University of Arizona
- Diseases
- High blood pressure
- NCT number
- NCT05610059
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 2 Nov 2022 to the primary completion date, 14 Mar 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- been instructed by their healthcare provider to withhold their blood pressure medication
Other illness
- are at risk for cognitive impairment (\< 23 on Montreal Cognitive Assessment, MoCA)
Other
- have inadequate visual acuity (worse than 20/50 corrected near vision on Snellen test)
- experience severe depression (\> 11 on Geriatric Depression Scale Short Form, GDS-15)
Who the study is looking for
- age 65 years or older
- self-manage at least one hypertension medication
- able to read and speak English
- willing to participate in the study for six months
- currently have and use an Apple iPhone
- have hypertension medication adherence ≤ 90% in the last 2 weeks of the 4-week baseline monitoring period using an AARDEX MEMS® cap
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Illinois Urbana-Champaign Coordinator of this site? Confirm its status | Champaign | United States | Unknown status |
| University of Arizona Coordinator of this site? Confirm its status | Tucson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.